Collectively, we conclude that one of the pivotal mechanisms of action whereby 5-AcTMF exerts its anti-GBM effect is through targeted suppression of the antiapoptotic JAK2-STAT3-BCL-2/BCL-xL signaling axis. The gene discussed is BCL2; the disease is glioblastoma.